Samrat Pharmachem Ltd.

BSE: 530125

Value Stock, Under Radar

Download real time

329.60 4.75 (1.46%)

New 52W Low in past week

663 BSE Volume

BSE 25 Mar, 2025 10:16 AM (IST)

101.8

Market Cap

Below industry Median

0.7

Beta 1Year

Very Low volatility

Samrat Pharmachem Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Samrat Pharmachem Ltd. on BSE

Load latest

Samrat Pharmachem Ltd.

04 Sep 2024

329.60

1.46%

Corp. Action

SAMRAT PHARMACHEM LTD.-$ - 530125 - Record Date: Thursday, September 19, 2024

BSE India

The Company has fixed Thursday, September 19, 2024 as the Record Date for the purpose of determining the Members eligible to receive dividend.

Samrat Pharmachem Ltd.

04 Sep 2024

329.60

1.46%

Corp. Note

SAMRAT PHARMACHEM LTD.-$ - 530125 - Reg. 34 (1) Annual Report.

BSE India

32nd Annual Report for FY: 2023-24

Samrat Pharmachem Ltd.

04 Sep 2024

329.60

1.46%

AGM

SAMRAT PHARMACHEM LTD.-$ - 530125 - 32Nd Annual General Meeting On Thursday, September 26, 2024

BSE India

32nd AGM on Thursday, September 26, 2024 at 2.00 PM (IST) through VC/ OAVM

Samrat Pharmachem Ltd.

23 Aug 2024, 03:37PM

329.60

1.46%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Extract of Standalone Un-Audited Financial Results for the quarter ended June 30, 2024

Samrat Pharmachem Ltd.

13 Aug 2024

329.60

1.46%

Result

SAMRAT PHARMACHEM LTD.-$ - 530125 - Un-Audited Financial Results For The Quarter Ended June 30, 2024

BSE India

Un-audited Financial Results for the quarter ended June 30, 2024

Samrat Pharmachem Ltd.

13 Aug 2024

329.60

1.46%

Board Meeting

SAMRAT PHARMACHEM LTD.-$ - 530125 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

The Board has considered and took on record the Un-audited Financial Results for the quarter ended June 30, 2024.

Samrat Pharmachem Ltd.

07 Aug 2024

329.60

1.46%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of Non - Executive Independent Director

Samrat Pharmachem Ltd.

25 Jul 2024

329.60

1.46%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of Mr. Manishkumar Indukumar Pipalia and Mr. Sachin Samir Kothary as Non-Executive Independent Directors of the Company for a term of 5 consecutive years each with effect from July 23, 2024, subject to approval of the shareholders at the forthcoming 32nd AGM.

Samrat Pharmachem Ltd.

18 Jul 2024

329.60

1.46%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under regulation 74(5) for the quarter ended June 30, 2024

Samrat Pharmachem Ltd.

04 Jul 2024

329.60

1.46%

Company Update

SAMRAT PHARMACHEM LTD.-$ - 530125 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Mr. Mahendra Pipalia & Mr. Samir Kothary, Independent Directors of the Company have tendered resignation from the close of business hours on 28th June 2024.

No results found

Is Samrat Pharmachem Ltd. worth buying?

44 Votes:

Buy 68.18%

Sell 13.64%

Hold 18.18%